Document Detail


Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.
MedLine Citation:
PMID:  21059987     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate the cause of diagnostic errors in the visual interpretation of positron emission tomographic scans with fludeoxyglucose F 18 (FDG-PET) in patients with frontotemporal lobar degeneration (FTLD) and patients with Alzheimer disease (AD).
DESIGN: Twelve trained raters unaware of clinical and autopsy information independently reviewed FDG-PET scans and provided their diagnostic impression and confidence of either FTLD or AD. Six of these raters also recorded whether metabolism appeared normal or abnormal in 5 predefined brain regions in each hemisphere-frontal cortex, anterior cingulate cortex, anterior temporal cortex, temporoparietal cortex, and posterior cingulate cortex. Results were compared with neuropathological diagnoses.
SETTING: Academic medical centers.
PATIENTS: Forty-five patients with pathologically confirmed FTLD (n=14) or AD (n=31).
RESULTS: Raters had a high degree of diagnostic accuracy in the interpretation of FDG-PET scans; however, raters consistently found some scans more difficult to interpret than others. Unanimity of diagnosis among the raters was more frequent in patients with AD (27 of 31 patients [87%]) than in patients with FTLD (7 of 14 patients [50%]) (P=.02). Disagreements in interpretation of scans in patients with FTLD largely occurred when there was temporoparietal hypometabolism, which was present in 7 of the 14 FTLD scans and 6 of the 7 scans lacking unanimity. Hypometabolism of anterior cingulate and anterior temporal regions had higher specificities and positive likelihood ratios for FTLD than temporoparietal hypometabolism had for AD.
CONCLUSIONS: Temporoparietal hypometabolism in FTLD is common and may cause inaccurate interpretation of FDG-PET scans. An interpretation paradigm that focuses on the absence of hypometabolism in regions typically affected in AD before considering FTLD is likely to misclassify a significant portion of FTLD scans. Anterior cingulate and/or anterior temporal hypometabolism indicates a high likelihood of FTLD, even when temporoparietal hypometabolism is present. Ultimately, the accurate interpretation of FDG-PET scans in patients with dementia cannot rest on the presence or absence of a single region of hypometabolism but rather must take into account the relative hypometabolism of all brain regions.
Authors:
Kyle B Womack; Ramon Diaz-Arrastia; Howard J Aizenstein; Steven E Arnold; Nancy R Barbas; Bradley F Boeve; Christopher M Clark; Charles S DeCarli; William J Jagust; James B Leverenz; Elaine R Peskind; R Scott Turner; Edward Y Zamrini; Judith L Heidebrink; James R Burke; Steven T DeKosky; Martin R Farlow; Matthew J Gabel; Roger Higdon; Claudia H Kawas; Robert A Koeppe; Anne M Lipton; Norman L Foster
Related Documents :
18191587 - In vivo spect imaging of vesicular acetylcholine transporter using [(123)i]-ibvm in ear...
18572417 - Antemortem mri based structural abnormality index (stand)-scores correlate with postmor...
2636847 - Magnetic resonance imaging and clinical correlates of intellectual impairment in myoton...
12212787 - Brain mri hippocampal volume and prediction of clinical status in a mild cognitive impa...
12612817 - The value of anal endosonography compared with magnetic resonance imaging following the...
20175037 - A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-11-08
Journal Detail:
Title:  Archives of neurology     Volume:  68     ISSN:  1538-3687     ISO Abbreviation:  Arch. Neurol.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-03-15     Completed Date:  2011-05-19     Revised Date:  2012-03-07    
Medline Journal Info:
Nlm Unique ID:  0372436     Medline TA:  Arch Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  329-37     Citation Subset:  AIM; IM    
Affiliation:
Department of Neurology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390-9129, USA. kyle.womack@utsouthwestern.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age of Onset
Aged
Alzheimer Disease / metabolism,  pathology,  radionuclide imaging
Brain / pathology
Diagnosis, Differential
Diagnostic Errors
Female
Fluorodeoxyglucose F18 / diagnostic use
Frontotemporal Lobar Degeneration / metabolism*,  pathology,  radionuclide imaging*
Humans
Image Processing, Computer-Assisted
Male
Middle Aged
Neuropsychological Tests
Observer Variation
Parietal Lobe / metabolism*,  pathology,  radionuclide imaging*
Positron-Emission Tomography
Radiopharmaceuticals / diagnostic use
Reproducibility of Results
Temporal Lobe / metabolism*,  pathology,  radionuclide imaging*
Grant Support
ID/Acronym/Agency:
AG028377/AG/NIA NIH HHS; AG05133/AG/NIA NIH HHS; AG08671/AG/NIA NIH HHS; AG10124/AG/NIA NIH HHS; AG10129/AG/NIA NIH HHS; AG10133/AG/NIA NIH HHS; AG12300/AG/NIA NIH HHS; AG16573/AG/NIA NIH HHS; AG16976/AG/NIA NIH HHS; AG22394/AG/NIA NIH HHS; AG30006/AG/NIA NIH HHS; K23 AG030006-03/AG/NIA NIH HHS; K23 AG030006-05/AG/NIA NIH HHS; P30 AG010124-17/AG/NIA NIH HHS; P30 AG010129-10/AG/NIA NIH HHS; P30 AG010129-19/AG/NIA NIH HHS; P30 AG010133-15/AG/NIA NIH HHS; P30 AG012300-15/AG/NIA NIH HHS; P30 AG028377-029001/AG/NIA NIH HHS; P30 AG028377-04/AG/NIA NIH HHS; P50 AG005133-23/AG/NIA NIH HHS; P50 AG008671-199001/AG/NIA NIH HHS; R01 AG022394-01/AG/NIA NIH HHS; U01 AG016976-03/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Advances in translational research in neuro-oncology.
Next Document:  Vitamin d, pregnancy, breastfeeding, and postpartum multiple sclerosis relapses.